Title:
COMBINATION THERAPIES FOR TREATING MUSCULAR DYSTROPHY
Document Type and Number:
WIPO Patent Application WO/2019/067981
Kind Code:
A8
Abstract:
The present disclosure relates to methods of treating Duchenne's Muscular Dystrophy by administering an antisense oligonucleotide that induces exon skipping and a non-steroidal anti-inflammatory compound.
Inventors:
PASSINI, Marco A. (215 First Street, Cambridge, Massachusetts, 02142, US)
MILNE, Jill C. (One Kendall Square, Cambridge, Massachusetts, 02139, US)
NICHOLS, Andrew J. (One Kendall Square, Cambridge, Massachusetts, 02139, US)
MILNE, Jill C. (One Kendall Square, Cambridge, Massachusetts, 02139, US)
NICHOLS, Andrew J. (One Kendall Square, Cambridge, Massachusetts, 02139, US)
Application Number:
US2018/053545
Publication Date:
May 31, 2019
Filing Date:
September 28, 2018
Export Citation:
Assignee:
SAREPTA THERAPEUTICS, INC. (215 First Street, Cambridge, Massachusetts, 02142, US)
CATABASIS PHARMACEUTICALS, INC. (One Kendall Square, Suite B14202Cambridge, Massachusetts, 02139, US)
CATABASIS PHARMACEUTICALS, INC. (One Kendall Square, Suite B14202Cambridge, Massachusetts, 02139, US)
International Classes:
A61K45/06; A61K31/166; A61K31/7125; A61P21/00
Attorney, Agent or Firm:
GILLENTINE, Marsha Rose et al. (STERNE, KESSLER GOLDSTEIN & FOX P.L.L.C.,1100 New York Avenue, N, Washington District of Columbia, 20005, US)
Download PDF:
Previous Patent: COMPUTING MEMORY ARCHITECTURE
Next Patent: PRODUCTION OF ADENO-ASSOCIATED VIRUSES IN INSECT CELLS
Next Patent: PRODUCTION OF ADENO-ASSOCIATED VIRUSES IN INSECT CELLS